GlassScriptPhysician profile
Brett A Malchow
NPI 1558656967
$5,576.37
in general payments reported to CMS, 2019-2025
39 companies · $819 in 2025
The $819 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $531 · 2020: $669 · 2021: $1,137 · 2022: $898 · 2023: $702 · 2024: $819 · 2025: $819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,340.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,686.13 | 2020-2025 | |
| Glaxosmithkline, LLC. | $459.32 | 2019-2021 | |
| Novo Nordisk INC | $359.25 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $323.61 | 2019-2024 | Otezla, Repatha |
| Lilly USA, LLC | $290.59 | 2019-2024 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $278.30 | 2021-2025 | |
| Allergan, INC. | $248.66 | 2019-2020 | |
| Abbott Laboratories | $199.96 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $165.70 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $160.26 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $124.45 | 2021-2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $117.88 | 2019 | |
| Exact Sciences Corporation | $110.86 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $94.54 | 2025 | Caplyta |
| Sanofi-Aventis U.S. LLC | $86.97 | 2019-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Malchow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.